Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2,1,3-Benzothiadiazole-4-sulfonamide, N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]- REF: AN-AG0008W7CAS: 1135243-19-4 | 95% | 47,00 €~260,00 € | Mar 21 May 24 | |
VU 0255035 REF: TM-T23508CAS: 1135243-19-4 | 96.53% | 36,00 €~1.095,00 € | Mar 28 May 24 | |
VU 0255035 REF: 3D-KVB24319CAS: 1135243-19-4 | Min. 95% | A consultar | Lun 01 Jul 24 |
2,1,3-Benzothiadiazole-4-sulfonamide, N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-
CAS:1135243-19-4
Fórmula:
C18H20N6O3S2
Pureza:
95%
Forma y color:
Solid
Peso molecular:
432.5198
Ref: AN-AG0008W7
1g | 260,00 € | |
25mg | 47,00 € | |
100mg | 99,00 € | |
250mg | 137,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
VU 0255035
CAS:1135243-19-4
VU 0255035 is a highly selective, competitive and brain penetrant muscarinic M1 receptor antagonist with …
Fórmula:
C18H20N6O3S2
Pureza:
96.53%
Forma y color:
Solid
Peso molecular:
432.52
Ref: TM-T23508
1mg | 36,00 € | |
5mg | 78,00 € | |
10mg | 118,00 € | |
25mg | 242,00 € | |
50mg | 360,00 € | |
100mg | 531,00 € | |
500mg | 1.095,00 € | |
1ml*10 (DMSO) | 87,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
VU 0255035
CAS:1135243-19-4
VU0255035 is a drug that blocks the muscarinic acetylcholine receptor, which is used to treat …
Fórmula:
C18H20N6O3S2
Pureza:
Min. 95%
Peso molecular:
432.52 g/mol
Ref: 3D-KVB24319
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 1 de Julio de 2024